白血病·淋巴瘤
白血病·淋巴瘤
백혈병·림파류
Journal of Leukemia & Lymphoma
2015年
8期
460-463
,共4页
朱明%李延莉%王芝涛%陶千山%翟志敏
硃明%李延莉%王芝濤%陶韆山%翟誌敏
주명%리연리%왕지도%도천산%적지민
淋巴瘤,大B细胞,弥漫性%中性粒细胞/淋巴细胞比值%完全缓解%预后
淋巴瘤,大B細胞,瀰漫性%中性粒細胞/淋巴細胞比值%完全緩解%預後
림파류,대B세포,미만성%중성립세포/림파세포비치%완전완해%예후
Lymphoma,large B-cell,diffuse%Neutrophil to lymphocyte ratio%Complete response%Prognosis
目的 探讨弥漫大B细胞淋巴瘤(DLBCL)患者化疗前外周血中性粒细胞/淋巴细胞比值(NLR)与化疗疗效及预后之间的关系.方法 回顾性分析51例经病理活检及免疫组织化学诊断为DLBCL,并接受CHOP或R-CHOP方案化疗患者的临床病理资料,根据NLR中位数将患者分为低NLR组(NLR≤2.32)和高NLR组(NLR> 2.32),分析两组患者化疗后完全缓解(CR)及总体生存(OS)情况.计数资料的比较采用x 2检验,生存分析采用Kaplan-Meier法和Log-rank检验,危险因素分析采用Cox比例风险回归模型.结果 低NLR组化疗后CR率为71.4%(20/28),高NLR组为39.1%(9/23),差异有统计学意义(P=0.02).低NLR组1、2、3年总体累积生存率分别为96.4%、90.4%和72.3%,高NLR组分别为63.9%、52.7%和42.2%,差异有统计学意义(P=0.009).Cox多因素分析结果显示,化疗前外周血NLR> 2.32是影响预后的独立因素(P=0.016).结论 化疗前外周血NLR偏高提示患者疗效不佳,预后不良,是影响DLBCL患者生存情况的独立危险因素.
目的 探討瀰漫大B細胞淋巴瘤(DLBCL)患者化療前外週血中性粒細胞/淋巴細胞比值(NLR)與化療療效及預後之間的關繫.方法 迴顧性分析51例經病理活檢及免疫組織化學診斷為DLBCL,併接受CHOP或R-CHOP方案化療患者的臨床病理資料,根據NLR中位數將患者分為低NLR組(NLR≤2.32)和高NLR組(NLR> 2.32),分析兩組患者化療後完全緩解(CR)及總體生存(OS)情況.計數資料的比較採用x 2檢驗,生存分析採用Kaplan-Meier法和Log-rank檢驗,危險因素分析採用Cox比例風險迴歸模型.結果 低NLR組化療後CR率為71.4%(20/28),高NLR組為39.1%(9/23),差異有統計學意義(P=0.02).低NLR組1、2、3年總體纍積生存率分彆為96.4%、90.4%和72.3%,高NLR組分彆為63.9%、52.7%和42.2%,差異有統計學意義(P=0.009).Cox多因素分析結果顯示,化療前外週血NLR> 2.32是影響預後的獨立因素(P=0.016).結論 化療前外週血NLR偏高提示患者療效不佳,預後不良,是影響DLBCL患者生存情況的獨立危險因素.
목적 탐토미만대B세포림파류(DLBCL)환자화료전외주혈중성립세포/림파세포비치(NLR)여화료료효급예후지간적관계.방법 회고성분석51례경병리활검급면역조직화학진단위DLBCL,병접수CHOP혹R-CHOP방안화료환자적림상병리자료,근거NLR중위수장환자분위저NLR조(NLR≤2.32)화고NLR조(NLR> 2.32),분석량조환자화료후완전완해(CR)급총체생존(OS)정황.계수자료적비교채용x 2검험,생존분석채용Kaplan-Meier법화Log-rank검험,위험인소분석채용Cox비례풍험회귀모형.결과 저NLR조화료후CR솔위71.4%(20/28),고NLR조위39.1%(9/23),차이유통계학의의(P=0.02).저NLR조1、2、3년총체루적생존솔분별위96.4%、90.4%화72.3%,고NLR조분별위63.9%、52.7%화42.2%,차이유통계학의의(P=0.009).Cox다인소분석결과현시,화료전외주혈NLR> 2.32시영향예후적독립인소(P=0.016).결론 화료전외주혈NLR편고제시환자료효불가,예후불량,시영향DLBCL환자생존정황적독립위험인소.
Objective To explore the neutrophil to lymphocyte ratio (NLR) and its relationship with the effect of chemotherapy and prognosis in patients with diffuse large B-cell lymphoma (DLBCL).Methods The clinicopathological characteristics and outcome of 51 patients with DLBCL diagnosed by pathological biopsy and immunohistochemistry who received CHOP or R-CHOP regimen were collected and reviewed.According to the median of NLR,the patients were divided into low NLR group (NLR≤2.32) and high NLR group (NLR>2.32).The prognostic influence of the NLR on overall survival (OS) was studied by Kaplan-Meier method and Log-rank test.To evaluate the independent prognostic relevance of NLR,univariate and multivariate Cox regression models were applied.Results The complete response (CR) rates of the low and high NLR groups were 71.4 % (20/28) and 39.1% (9/23),respectively (P =0.02).The OS in the low NLR group was significantly better than that in the high NLR group (1,2 and 3-year OSs were 96.4 %,90.4 % and 72.3 % vs 63.9 %,52.7 % and 42.2 %,respectively,P =0.009).Univariate and multivariate Cox regression models analysis showed that NLR > 2.32 was an independent prognostic factor (P =0.016).Conclusion An elevated NLR before treatment indicates the poor effect of chemotherapy and prognosis of patients.NLR is an independent prognostic factor for DLBCL.